Insys files for bankruptcy on the heels of $225M kickback settlement with the feds

Insys Therapeutics settled with the feds for $225M on federal kickback charges, but things continue to escalate for the opioid maker.

 

Insys filed for Chapter 11 bankruptcy on the heels of an agreement with the Department of Justice to pay civil and criminal penalties to tie up charges that the company paid doctors to boost scripts of its fentanyl spray Subsys. Insys will look to sell almost all of its assets within 90 days.

 

Read the full article at fiercepharma.com…

Comments are closed.

More in Ashton Tweed Connection, News & Trends
Novartis gene therapy approved, but will come at cost of more than $2 million

A gene therapy approved by the FDA offers a potential one-time fix for a rare genetic condition known as spinal...

Close